[HTML][HTML] Monocyte-released HERV-K dUTPase engages TLR4 and MCAM causing endothelial mesenchymal transition
We previously reported heightened expression of the human endogenous retroviral protein
HERV-K deoxyuridine triphosphate nucleotidohydrolase (dUTPase) in circulating …
HERV-K deoxyuridine triphosphate nucleotidohydrolase (dUTPase) in circulating …
[HTML][HTML] The interactions between cancer stem cells and the innate interferon signaling pathway
L Martin-Hijano, B Sainz Jr - Frontiers in Immunology, 2020 - frontiersin.org
Interferons (IFNs) form a family of cytokines with pleiotropic effects that modulate the immune
response against multiple challenges like viral infections, autoimmune diseases, and …
response against multiple challenges like viral infections, autoimmune diseases, and …
[HTML][HTML] Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs
MP Hardy, É Audemard, F Migneault, A Feghaly… - Scientific Reports, 2019 - nature.com
Endothelial cells have multifaceted interactions with the immune system, both as initiators
and targets of immune responses. In vivo, apoptotic endothelial cells release two types of …
and targets of immune responses. In vivo, apoptotic endothelial cells release two types of …
[HTML][HTML] Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity
JC Kim, X Liu, K Fitzgerald, JS Eng, J Orf… - Cancer Immunology …, 2023 - Springer
Type I interferon-mediated activation of immune cells can facilitate the generation of
productive tumor antigen-specific T cell responses in solid tumors. The cGAS/STING DNA …
productive tumor antigen-specific T cell responses in solid tumors. The cGAS/STING DNA …
Targeting DDX3X triggers antitumor immunity via a dsRNA-mediated tumor-intrinsic type I interferon response
Induction of nucleic acid sensing–mediated type I interferon (IFN) has emerged as a novel
approach to activate the immune system against cancer. Here we show that the depletion of …
approach to activate the immune system against cancer. Here we show that the depletion of …
MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer
R Yoshida, M Saigi, T Tani, BF Springer, H Shibata… - Cancer research, 2022 - AACR
Immunotherapy has shown limited efficacy in patients with EGFR-mutated lung cancer.
Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been …
Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been …
[HTML][HTML] Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
Small cell lung cancer (SCLC) is classified as a high-grade neuroendocrine (NE) tumor, but
a subset of SCLC has been termed “variant” due to the loss of NE characteristics. In this …
a subset of SCLC has been termed “variant” due to the loss of NE characteristics. In this …
Epigenetic therapies in acute myeloid leukemia: where to from here?
KA Fennell, CC Bell, MA Dawson - Blood, The Journal of the …, 2019 - ashpublications.org
A hallmark of acute myeloid leukemia (AML) is epigenetic dysregulation, which is initiated by
recurrent translocations and/or mutations in transcription factors and chromatin regulators …
recurrent translocations and/or mutations in transcription factors and chromatin regulators …
[HTML][HTML] Transcriptional regulation of endogenous retroviruses and their misregulation in human diseases
Q Zhang, J Pan, Y Cong, J Mao - International Journal of Molecular …, 2022 - mdpi.com
Endogenous retroviruses (ERVs), deriving from exogenous retroviral infections of germ line
cells occurred millions of years ago, represent~ 8% of human genome. Most ERVs are …
cells occurred millions of years ago, represent~ 8% of human genome. Most ERVs are …
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens
MM Wolf, WK Rathmell, AA de Cubas - Nature Reviews Nephrology, 2023 - nature.com
Renal cell carcinoma (RCC) comprises a group of malignancies arising from the kidney with
unique tumour-specific antigen (TSA) signatures that can trigger cytotoxic immunity. Two …
unique tumour-specific antigen (TSA) signatures that can trigger cytotoxic immunity. Two …